Alistair Macdonald
CIK 1624073 · Chief Executive Officer · last filed 2022-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$96.1K
Companies
2
Total Filings
55
Lifetime Open-Market Net
-$30.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Syneos Health, Inc. (SYNH) Delisted | Chief Executive Officer | 254,892 | $42.98 | $10.96M | -$15.12M | 35 | 2022-03-04 |
| INCR | Chief Executive Officer | 99,453 | $0.97 | $96.1K | -$14.94M | 20 | 2017-09-19 |
Recent Filings · Page 2 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-20 | Syneos Health, Inc. (SYNH) Delisted | Mixed | +39,507 | -$576.3K | EDGAR |
| 2021-01-11 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −10,154 | -$747.2K | EDGAR |
| 2020-12-28 | Syneos Health, Inc. (SYNH) Delisted | Sell (S) | −1,500 | -$105.2K | EDGAR |
| 2020-08-04 | Syneos Health, Inc. (SYNH) Delisted | Mixed | −14,467 | -$941.3K | EDGAR |
| 2020-07-17 | Syneos Health, Inc. (SYNH) Delisted | Mixed | — | -$1.25M | EDGAR |
| 2020-07-15 | Syneos Health, Inc. (SYNH) Delisted | Mixed | — | -$423.0K | EDGAR |
| 2020-04-15 | Syneos Health, Inc. (SYNH) Delisted | Mixed | +43,475 | $0 | EDGAR |
| 2020-02-20 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −12,451 | -$828.1K | EDGAR |
| 2020-01-29 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −13,545 | -$849.1K | EDGAR |
| 2020-01-22 | Syneos Health, Inc. (SYNH) Delisted | Tax (F) | −1,293 | -$82.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.